Related Experiment Video
Updated: Jun 28, 2025

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
miR-192 family in breast cancer: Regulatory mechanisms and diagnostic value
Mingxuan Yu1, Hua Du2, Caihong Zhang1
1Department of Laboratory Medicine, Affiliated Hospital of Inner Mongolia Medical University, PR China.
Abstract:
There is a growing interest in the role of the miRNA family in human cancer. The miRNA-192 family is a group of conserved small RNAs, including miR-192, miR-194, and miR-215. Recent studies have shown that the incidence and mortality of breast cancer have been increasing epidemiologically year by year, and it is urgent to clarify the pathogenesis of breast cancer and seek new diagnostic and therapeutic methods. There is increasing evidence that miR-192 family members may be involved in the occurrence and development of breast cancer. This review describes the regulatory mechanism of the miRNA-192 family affecting the malignant behavior of breast cancer cells and evaluates the value of the miRNA-192 family as a diagnostic and prognostic biomarker for breast cancer. It is expected that summarizing and discussing the relationship between miRNA-192 family members and breast cancer, it will provide a new direction for the clinical diagnosis and treatment of breast cancer and basic medical research.
Related Concept Videos
MicroRNAs
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

